scholarly journals Short Communication: From Wasting to Obesity: Initial Antiretroviral Therapy and Weight Gain in HIV-Infected Persons

2013 ◽  
Vol 29 (3) ◽  
pp. 435-440 ◽  
Author(s):  
Wanda Lakey ◽  
Lan-Yan Yang ◽  
William Yancy ◽  
Shein-Chung Chow ◽  
Charles Hicks
Keyword(s):  
Weight Gain ◽  
Antiretroviral Therapy ◽  
Short Communication

scholarly journals 231 The effect of antiretroviral therapy regimens on gestational weight gain in pregnant women with HIV

2021 ◽  
Vol 224 (2) ◽  
pp. S152-S153
Author(s):  
Naima T. Joseph ◽  
Glen Satten ◽  
Rachel Williams ◽  
Martina Badell ◽  
Anandi Sheth
Keyword(s):  
Weight Gain ◽  
Antiretroviral Therapy ◽  
Pregnant Women ◽  
Gestational Weight Gain ◽  
Gestational Weight ◽  
Women With Hiv

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

AIDS ◽  
2009 ◽  
Vol 27 (7) ◽  
pp. 853-861 ◽  
Author(s):  
Yoann Madec ◽  
Elisabeth Szumilin ◽  
Christine Genevier ◽  
Laurent Ferradini ◽  
Suna Balkan ◽  
...  
Keyword(s):  
Developing Countries ◽  
Weight Gain ◽  
Antiretroviral Therapy

scholarly journals An audit of how patients get on to antiretroviral therapy in Malawi, and the weight gain they experience in the first six months

2008 ◽  
Vol 19 (3) ◽  
Author(s):  
T Bizuwork ◽  
S D Makombe ◽  
K Kamoto ◽  
M Hochgesang ◽  
A D Harries
Keyword(s):  
Weight Gain ◽  
Antiretroviral Therapy

scholarly journals Short Communication: Reversible Mitochondrial Respiratory Chain Impairment During Symptomatic Hyperlactatemia Associated with Antiretroviral Therapy

2003 ◽  
Vol 19 (11) ◽  
pp. 1027-1032 ◽  
Author(s):  
Òscar Miró ◽  
Sònia López ◽  
Esteban Martínez ◽  
Benjamín Rodríguez-Santiago ◽  
José L. Blanco ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Respiratory Chain ◽  
Short Communication ◽  
Mitochondrial Respiratory Chain ◽  
Mitochondrial Respiratory

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

Infection ◽  
2019 ◽  
Vol 48 (2) ◽  
pp. 213-221 ◽  
Author(s):  
Leonardo Calza ◽  
Vincenzo Colangeli ◽  
Marco Borderi ◽  
Isabella Bon ◽  
Aurora Borioni ◽  
...  
Keyword(s):  
Weight Gain ◽  
Antiretroviral Therapy ◽  
Strand Transfer ◽  
Transfer Inhibitor ◽  
Integrase Strand Transfer Inhibitor ◽  
Hiv 1

Short Communication: Persistence of HIV Antibody Avidity in the Presence of Antiretroviral Therapy

2016 ◽  
Vol 32 (6) ◽  
pp. 561-563 ◽  
Author(s):  
Kelly A. Curtis ◽  
Krystin Ambrose Price ◽  
Philip Niedzwiedz ◽  
Silvina Masciotra ◽  
Michele Owen
Keyword(s):  
Antiretroviral Therapy ◽  
Short Communication ◽  
Antibody Avidity

Short Communication: Non-B HIV Type 1 Subtypes: Replicative Capacity and Response to Antiretroviral Therapy

2004 ◽  
Vol 20 (8) ◽  
pp. 816-818 ◽  
Author(s):  
Emanuele Nicastri ◽  
Loredana Sarmati ◽  
Gabriella D'Ettorre ◽  
Saverio G. Parisi ◽  
Lucia Palmisano ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Short Communication ◽  
Replicative Capacity ◽  
Hiv Type 1

Short Communication: Birdsfoot trefoil as a preventative treatment for gastrointestinal nematodes in pastured dairy heifers

2015 ◽  
Vol 95 (4) ◽  
pp. 533-537 ◽  
Author(s):  
E. Shepley ◽  
E. Vasseur ◽  
R. Bergeron ◽  
A. Villeneuve ◽  
S. Lachance
Keyword(s):  
Weight Gain ◽  
Short Communication ◽  
Parasite Burden ◽  
Gastrointestinal Nematodes ◽  
Birdsfoot Trefoil ◽  
Preventative Treatment ◽  
Dairy Heifers ◽  
Fold Reduction ◽  
Alfalfa Silage ◽  
Detrimental Impact

Shepley, E., Vasseur, E., Bergeron, R., Villeneuve, A. and Lachance, S. 2015. Short Communication: Birdsfoot trefoil as a preventative treatment for gastrointestinal nematodes in pastured dairy heifers. Can. J. Anim. Sci. 95: 533–537. Bioactive forages, such as birdsfoot trefoil, may serve as an alternative to anthelmintic drugs in pastured dairy heifers. Differences in parasite burden and growth were examined between eight treatment heifers fed a birdsfoot trefoil mixture and nine control heifer fed alfalfa silage 45-min per day for 12 wk. A significant 3.8- to 9.4-fold reduction in fecal egg counts was observed for treatment heifers at weeks 5, 9, 11 and 12. No treatment effect was found for weight gain. Our results suggest that birdsfoot trefoil may reduce parasite fecal egg counts in pastured dairy heifers without detrimental impact on growth.

scholarly journals 334. Weight Change Associated with Antiretroviral Therapy Switch to Integrase Strand Transfer Inhibitor-Based Regimens

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S177-S177 ◽  
Author(s):  
Saghar Saber ◽  
Andrew B Bernstein ◽  
Andrew D Sparks ◽  
Marc O Siegel
Keyword(s):  
Weight Gain ◽  
Antiretroviral Therapy ◽  
Weight Change ◽  
Statistical Significance ◽  
Inverse Correlation ◽  
Cd4 Count ◽  
Strand Transfer ◽  
Significant Difference ◽  
Transfer Inhibitor ◽  
Integrase Strand Transfer Inhibitor

Abstract Background An association between switching antiretroviral therapy (ART) to integrase strand transfer inhibitor (INSTI)-based ART and weight gain has been previously reported. However, insufficient data exists on risk factors associated with such weight gain. Methods We reviewed charts of 119 virally-suppressed HIV-positive patients switched from nonnucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI)-based ART to INSTI-based ART and compared their weight change over 17 months to 56 virally-suppressed patients who were maintained on NNRTI-based regimens over the same period.We looked at variables associated with weight gain including age, weight, body mass index (BMI), gender, CD4 count, starting ART, and final INSTI-based ART. Results The 119 patients switched to INSTI-based ART gained an average of 6.9 lbs compared with an average 1 lbs weight gain in the 56 patients who were maintained on NNRTI-based ART (P = 0.002). There was also a statistically significant difference in the percentage % weight change between the two groups (4.2% vs. 0.7%, P < 0.001).There was an average 1.2 lbs weight loss in 92 of the 119 patients with weights recorded 17 months before switching ART, compared with an average 6.7 lbs weight gain after the switch (P < 0.001).There was no association between gender, CD4 count at the time of switch, starting ART, or final INSTI-based ART with weight gain. However, patients weighing < 150 lbs at the time of switch had a greater % weight gain than patients weighing >200 lbs (6.9% vs. 2.7%, P = 0.02) and a trend to greater % weight gain than those weighing ≥150 to ≤ 200 lbs (6.9% vs. 3.8%, P = 0.06). There was marginal statistical significance when comparing those with BMIs < 25 to those with BMIs ≥25 to ≤ 30 (8.2 vs. 6.5 lbs, P = 0.069) and those with BMIs >30 (8.2 vs. 5.0 lbs, P = 0.057). There was an inverse correlation between age and weight gain, indicating that less weight was gained when switching to INSTI-based ART as the age of the patient increased (ρ = -0.211, P = 0.021). Conclusion Our study showed a statistically significant weight gain in patients switched from NNRTI- or PI- to INSTI-based ART compared with patients maintained on NNRTI-based ART.Baseline variables associated with greater weight gain included weight <150 lbs, BMI <25 and younger age. Disclosures All authors: No reported disclosures.

Sign in / Sign up

Export Citation Format

Share Document